EUVIMEDEUVIMED entdecken
Crossref

Structure-Based Drug Design with Geometric Deep Learning: A Comprehensive Survey

Zaixi Zhang, Jiaxian Yan, Yining Huang, Qi Liu, Enhong Chen, Mengdi Wang, Marinka Zitnik

ACM Computing Surveys · 30.04.2026 · 58 (5) · 1-35

DOI: 10.1145/3769677 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACM Computing Surveys, online erschienen am 21.11.2025. Verfasst von Zaixi Zhang und 6 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 238 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Structure-based drug design (SBDD) leverages the three-dimensional geometry of proteins to identify potential drug candidates. Traditional approaches, rooted in physicochemical modeling and domain expertise, are often resource-intensive. Recent advancements in geometric deep learning, which effectively integrate and process 3D geometric data, alongside breakthroughs in accurate protein structure predictions from tools like AlphaFold, have significantly propelled the field forward. This article systematically reviews the state-of-the-art in geometric deep learning for SBDD. We begin by outlining foundational tasks in SBDD, discussing prevalent 3D protein representations, and highlighting representative predictive and generative models. Next, we provide an in-depth review of key tasks, including binding site prediction, binding pose generation, de novo molecule generation, linker design, protein pocket generation, and binding affinity prediction. For each task, we present formal problem definitions, key methods, datasets, evaluation metrics, and performance benchmarks. Lastly, we explore current challenges and future opportunities in SBDD. Challenges include oversimplified problem formulations, limited out-of-distribution generalization, biosecurity concerns related to the misuse of structural data, insufficient evaluation metrics and large-scale benchmarks, and the need for experimental validation and enhanced model interpretability. Opportunities lie in integrating biomedical AI agents, leveraging multimodal datasets, developing comprehensive benchmarks, establishing criteria aligned with clinical outcomes, and designing foundation models to expand the scope of design tasks. We also curate https://github.com/zaixizhang/Awesome-SBDD , reflecting ongoing contributions and new datasets in SBDD.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, Z., Yan, J., Huang, Y., Liu, Q., Chen, E., Wang, M., & Zitnik, M. (2026). Structure-Based Drug Design with Geometric Deep Learning: A Comprehensive Survey. ACM Computing Surveys, 58(5), 1-35. https://doi.org/10.1145/3769677

Vancouver

Zhang Z, Yan J, Huang Y, Liu Q, Chen E, Wang M, et al. Structure-Based Drug Design with Geometric Deep Learning: A Comprehensive Survey. ACM Computing Surveys. 2026;58(5):1-35. doi:10.1145/3769677

BibTeX
@article{Zhang2026,
  author = {Zhang, Zaixi and Yan, Jiaxian and Huang, Yining and Liu, Qi and Chen, Enhong and Wang, Mengdi and Zitnik, Marinka},
  title = {Structure-Based Drug Design with Geometric Deep Learning: A Comprehensive Survey},
  journal = {ACM Computing Surveys},
  year = {2026},
  volume = {58},
  number = {5},
  pages = {1--35},
  doi = {10.1145/3769677}
}
Kostenlos starten →